Promunel - New clinical study on the prevention of seasonal discomforts
Promunel - New clinical study on the prevention of seasonal discomforts
Promunel has been clinically proven to improve the comfort of the upper respiratory tract within 3 days. (Esposito et al.; Phytomedicine; 2020)
New release at Supplyside West
Fytexia will present the results of a new study involving 295 subjects, which demonstrates the immunomodulatory effect of Promunel in reducing the incidence and risk of respiratory discomforts during the autumn-to-spring period.
Promunel supplementation is now demonstrated to:
- reduce the incidence of upper respiratory discomforts
- shorten the number of days with discomforts
- delay the occurrence of seasonal discomforts
BOOK YOUR INTRODUCTION MEETING
NEW l Double-blind, randomized, placebo-controlled study.
Promunel supplementation reduces significantly the number of subjects experiencing upper respiratory discomforts by 26% over cough and cold period.
This website is intended to provide information about Fytexia’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business to business and to provide information to food/dietary supplement professionals and is not designed for the general public. Statements used on this website have not been evaluated by the Food and Drug Administration or any other competent authority. Products are not intended to diagnose, treat, cure or prevent any disease.
